Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.EMA Approves Factor VIII Deficiency Clotting Drug EMA Approves Factor VIII Deficiency Clotting Drug
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Europe Recommends Three Cancer Drugs Europe Recommends Three Cancer Drugs
The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Pancreatic Fat Is the Main Driver for Pancreatic Diseases Pancreatic Fat Is the Main Driver for Pancreatic Diseases
The diffused presence of fat within the pancreas was the single most important driver for diseases of both the exocrine pancreas and endocrine pancreas, a recent study reported.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Gastroenterology Clinical Summary Source Type: news
Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue Don't Miss the Dx: Woman Has Unintended Weight Loss, Fatigue
Are you familiar with the presentation, workup, treatment, and monitoring of CML? Dr Adam Braun provides a brief guide.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Timing Is Everything: CAR T for Follicular Lymphoma Timing Is Everything: CAR T for Follicular Lymphoma
CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
' We Need to Rethink Our Options': Lung Cancer Recurrence'We Need to Rethink Our Options': Lung Cancer Recurrence
Dr Mark Kris discusses the emerging issue of recurrence in the chest resulting from improved systemic therapies.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Is the FDA Pausing More Cancer Trials? It's Hard to Tell Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Clinical trial holds delay therapies getting to market and may be on the rise in oncology. But there ' s a lot the public doesn ' t know about how often these holds happen and why.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Chronic Myelogenous Leukemia (CML): 5 Things to Know Chronic Myelogenous Leukemia (CML): 5 Things to Know
Advanced and emerging therapies in CML offer significantly improved survival. These five things to know will help elucidate potential pitfalls and pearls to successful management.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
AI in Cancer Care: Use, Understanding, and Responsibility AI in Cancer Care: Use, Understanding, and Responsibility
Dr Maurie Markman discusses the evolving world of artificial intelligence as it affects cancer care.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
FDA Approves New Bladder Cancer Drug FDA Approves New Bladder Cancer Drug
The first-in-class agent is approved alongside bacillus Calmette-Gu érin to treat certain non–muscle-invasive bladder cancers that do not respond to bacillus Calmette-Guérin alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Is Osimertinib Better Alone or With Chemotherapy in NSCLC? Is Osimertinib Better Alone or With Chemotherapy in NSCLC?
A new study reveals that baseline EGFR mutations may be key to making the decision in the frontline setting.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines
Only 4% of cancer survivors reported adhering to four key healthy lifestyle practices endorsed by the American Cancer Society.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Hair Loss: Experts Provide Recommendations on Oral Minoxidil Hair Loss: Experts Provide Recommendations on Oral Minoxidil
The authors " identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients. "MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2024 Category: Cancer & Oncology Tags: Dermatology News Source Type: news
Has Immunotherapy Found Its Place in Pancreatic Cancer? Has Immunotherapy Found Its Place in Pancreatic Cancer?
A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Alectinib Approved for ALK-Positive Adjuvant NSCLC Alectinib Approved for ALK-Positive Adjuvant NSCLC
The approval makes alectinib the first ALK inhibitor approved for early-stage NSCLC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
